Advanced Biomed Inc. (NASDAQ: ADVB)

Sector: Healthcare Industry: Diagnostics & Research CIK: 0001941029
Market Cap 5.54 Mn
P/B 0.58
P/E 1.26
P/S 0.00
ROIC (Qtr) -46.19
Div Yield % 0.00
Rev 1y % (Qtr) 0.00
Total Debt (Qtr) 21,092.00
Debt/Equity (Qtr) 0.00
Add ratio to table...

About

Investment thesis

Bull case

  • Healthy cash reserves of 2.60M provide 132.48x coverage of short-term debt 19661, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 10.85M provides 514.45x coverage of total debt 21092, indicating robust asset backing and low credit risk.
  • Cash reserves of 2.60M provide solid 22.83x coverage of other non-current liabilities 114065, indicating strong liquidity.
  • Cash reserves of 2.60M provide robust 2.08x coverage of current liabilities 1.25M, indicating strong short-term solvency.
  • Robust R&D investment of 907010 at 0.46x of SG&A 1.99M demonstrates strong commitment to innovation and future growth.

Bear case

  • Investment activities of (37041) provide weak support for R&D spending of 907010, which is -0.04x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Free cash flow of (6.11M) provides weak coverage of capital expenditures of 37041, with a -165.07 ratio suggesting additional external financing needs for growth initiatives.
  • Free cash flow of (6.11M) represents just -10.89x of debt issuance 561683, suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Retained earnings of (12.76M) provide limited buffer against comprehensive income items of 874748, which is -14.59x, indicating elevated exposure to market risks.
  • Operating cash flow of (6.08M) is outpaced by equity issuance of 5.53M (-1.10 ratio), indicating concerning reliance on equity markets for funding operations.

Peer comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 195.62 Bn 145.81 18.20 35.68 Bn
2 DHR Danaher Corp /De/ 150.95 Bn 25.70 7.18 16.86 Bn
3 IDXX Idexx Laboratories Inc /De 50.58 Bn 49.23 12.14 1.09 Bn
4 A Agilent Technologies, Inc. 35.16 Bn 26.99 5.06 3.35 Bn
5 DGX Quest Diagnostics Inc 32.69 Bn 61.34 4.50 6.38 Bn
6 NTRA Natera, Inc. 28.52 Bn -92.25 13.48 0.18 Bn
7 IQV Iqvia Holdings Inc. 28.27 Bn 20.79 1.73 15.95 Bn
8 MTD Mettler Toledo International Inc/ 27.89 Bn 32.09 6.93 2.15 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.27 2.51
EV to Cash from Ops. EV/CFO -0.48 23.19
EV to Debt EV to Debt 138.16 49.21
EV to EBIT EV/EBIT 0.66 13.76
EV to EBITDA EV/EBITDA -1.07 15.54
EV to Free Cash Flow [EV/FCF] EV/FCF -0.48 16.92
EV to Market Cap EV to Market Cap 0.53 1.99
EV to Revenue EV to Revenue 0.00 4.86
Price to Book Value [P/B] P/B 0.58 -21.66
Price to Earnings [P/E] P/E 1.26 12.88
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -1.84
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 2.86
Dividend per Basic Share Div per Share (Qtr) 0.00 0.19
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 1.94
Interest Coverage Interest Coverage 0.00 -137.21
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -3.34 -37.66
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -1.98 23.39
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.25
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 244.30 28.29
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -38.14 27.21
EBIT Growth (1y) % EBIT 1y % (Qtr) 244.30 25.03
EBT Growth (1y) % EBT 1y % (Qtr) 244.30 9.12
EPS Growth (1y) % EPS 1y % (Qtr) 226.67 32.52
FCF Growth (1y) % FCF 1y % (Qtr) -149.69 61.96
Gross Profit Growth (1y) % Gross Profit Growth (1y) % 0.00 185.72
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 0.57
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.01
Cash Ratio Cash Ratio (Qtr) 2.08 1.29
Current Ratio Curr Ratio (Qtr) 8.56 2.91
Debt to Equity Ratio Debt/Equity (Qtr) 0.00 -2.51
Interest Cover Ratio Interest Cover Ratio 0.00 -137.21
Times Interest Earned Times Interest Earned 0.00 -137.21
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % 0.00 -96.62
EBIT Margin % EBIT Margin % 0.00 -115.03
EBT Margin % EBT Margin % 0.00 -113.62
Gross Margin % Gross Margin % 0.00 44.75
Net Profit Margin % Net Profit Margin % 0.00 -112.47